SOFINOX Sodium Fusidate 2.0% Cream 5g
We recognize that purchasing medications can be a deeply personal matter. To respect your privacy, we ensure that all orders are packaged discreetly, with no indication of the contents on the packaging. This means that even our couriers remain unaware of the package contents.
Furthermore, we uphold strict confidentiality standards. We guarantee that your order information will never be disclosed to any third party. Your trust is paramount to us, and we are committed to safeguarding your privacy at every step of the process. Our dedication to discretion and confidentiality is part of our unwavering commitment to you, our valued customer.
Features
- Fusidate
Description
Indications/Uses
Dosage/Direction for Use
Storage
Action
The therapeutic efficacy of topically applied sodium fusidate is due partly to pronounced antibacterial activity of sodium fusidate against the organisms responsible for skin infection, and partly to the unique ability of this antibiotic to penetrate intact skin.
Pharmacodynamics: Fusidic acid disrupts translocation of peptide subunits and elongating the peptide chain of susceptible bacteria, thus inhibiting protein synthesis. The Chitosan demonstrates blood clotting, film forming, wound healing and skin restoration properties.
Pharmacokinetics: Fusidate is widely distributed into tissues and body fluids. It has been found in the fetal circulation and in breast milk. About 95% or more of fusidate in the circulation is bound to plasma proteins. Fusidate has a plasma half-life of about 10 to 15 hours. It is excreted in the bile, almost entirely as metabolites, some of which have weak antimicrobial activity. About 2% appears unchanged in the faeces. Little is excreted in the urine or removed by haemodialysis.